Coherus BioSciences, Inc. (CHRS) Deferred Tax Assets, Valuation Allowance USD 2013 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Coherus BioSciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2013 to 2023.
  • Coherus BioSciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $423 M, a 25.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $423 M +$85.6 M +25.3% Dec 31, 2023 10-K 2024-03-15
Q4 2022 $338 M +$64.4 M +23.6% Dec 31, 2022 10-K 2024-03-15
Q4 2021 $273 M +$72.4 M +36% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $201 M -$22.7 M -10.2% Dec 31, 2020 10-K 2022-02-23
Q4 2019 $224 M -$13.4 M -5.65% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $237 M +$54.6 M +30% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $182 M +$4.61 M +2.6% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $178 M +$43 M +31.9% Dec 31, 2016 10-K 2018-03-08
Q4 2015 $135 M +$79.2 M +142% Dec 31, 2015 10-K 2017-03-14
Q4 2014 $55.6 M +$22.1 M +66% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $33.5 M Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.